{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:45:45Z","timestamp":1787507145068,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004504","name":"Research Council of Lithuania","doi-asserted-by":"publisher","award":["SEN-12\/2015"],"award-info":[{"award-number":["SEN-12\/2015"]}],"id":[{"id":"10.13039\/501100004504","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ejphar.2018.09.005","type":"journal-article","created":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T14:58:47Z","timestamp":1536159527000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"838","author":[{"given":"Aida","family":"Vitkeviciene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Baksiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Borutinskaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruta","family":"Navakauskiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.09.005_bib1","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/sj.onc.1206236","article-title":"Methylation of CpG dinucleotides and\/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients","volume":"22","author":"Agirre","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejphar.2018.09.005_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","article-title":"Epigenetic therapeutics: a new weapon in the war against cancer","volume":"67","author":"Ahuja","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2018.09.005_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1158\/1541-7786.MCR-05-0121","article-title":"p53-independent regulation of p21Waf1\/Cip1 expression and senescence by Chk2","volume":"3","author":"Aliouat-Denis","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejphar.2018.09.005_bib4","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1182\/blood.V91.5.1700","article-title":"Bcr-Abl exerts its antiapoptotic effect against diverse apoptotic stimuli through blockage of mitochondrial release of cytochrome C and activation of caspase-3","volume":"91","author":"Amarante-Mendes","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.09.005_bib5","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","article-title":"European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013","volume":"122","author":"Baccarani","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.09.005_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/carcin\/bgp314","article-title":"The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival","volume":"31","author":"Balasubramanian","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejphar.2018.09.005_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2141.2009.08040.x","article-title":"Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2","volume":"149","author":"Britschgi","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2018.09.005_bib8","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2018.09.005_bib9","first-page":"3761","article-title":"A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents","volume":"59","author":"Chang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2018.09.005_bib10","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1464-410X.2004.04785.x","article-title":"Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line","volume":"93","author":"Chen","year":"2004","journal-title":"BJU Int."},{"key":"10.1016\/j.ejphar.2018.09.005_bib11","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12094-012-0894-z","article-title":"Methylation in the p53 promoter in epithelial ovarian cancer","volume":"15","author":"Chmelarova","year":"2013","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.ejphar.2018.09.005_bib12","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","article-title":"The histone H3 methyltransferase G9A epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation","volume":"18","author":"Ding","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejphar.2018.09.005_bib13","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1101\/gad.1463706","article-title":"Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication","volume":"20","author":"Est\u00e8ve","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejphar.2018.09.005_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/ng1531","article-title":"Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer","volume":"37","author":"Fraga","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejphar.2018.09.005_bib15","first-page":"1","article-title":"Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): an updated review","volume":"19","author":"Gan","year":"2016","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.ejphar.2018.09.005_bib16","first-page":"8","article-title":"Epigallocatechin gallate nanodelivery systems for cancer therapy","author":"Granja","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.ejphar.2018.09.005_bib17","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1074\/jbc.M109.062588","article-title":"G9a and Glp methylate lysine 373 in the tumor suppressor p53","volume":"285","author":"Huang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2018.09.005_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1182\/blood.V124.21.375.375","article-title":"Final analysis of the Australasian leukaemia and lymphoma Group (ALLG) APML4 trial: All-trans Retinoic acid (ATRA), Intravenous arsenic trioxide (ATO) and idarubicin (IDA) As Initial therapy for acute promyelocytic leukemia (APL)","volume":"124","author":"Iland","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.09.005_bib19","doi-asserted-by":"crossref","first-page":"9145","DOI":"10.1007\/s11033-012-1787-5","article-title":"Promoter hypermethylation of p73 and p53 genes in cervical cancer patients among north Indian population","volume":"39","author":"Jha","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.ejphar.2018.09.005_bib20","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/nar\/gkt012","article-title":"Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity","volume":"41","author":"J\u00f8rgensen","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejphar.2018.09.005_bib21","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/0092-8674(91)90112-C","article-title":"Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARA with a novel putative transcription factor, PML","volume":"66","author":"Kakizuka","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2018.09.005_bib22","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.3892\/or.2015.3802","article-title":"(-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells","volume":"33","author":"Khan","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ejphar.2018.09.005_bib23","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejphar.2018.09.005_bib24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1182\/blood.V77.5.1080.1080","article-title":"NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3)","volume":"77","author":"Lanotte","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.09.005_bib25","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0145-2126(93)90161-D","article-title":"Mutational inactivation of the p53 gene in the human erythroid leukemic K562 cell line","volume":"17","author":"Law","year":"1993","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2018.09.005_bib26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/jcp.21950","article-title":"Core binding factor at the crossroads: determining the fate of the HSC","volume":"222","author":"Link","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2018.09.005_bib27","doi-asserted-by":"crossref","first-page":"e103915","DOI":"10.1371\/journal.pone.0103915","article-title":"Inhibition of euchromatic histone methyltransferase 1 and 2 sensitizes chronic myeloid leukemia cells to interferon treatment","volume":"9","author":"Loh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2018.09.005_bib28","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1007\/s00277-015-2477-x","article-title":"Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients","volume":"94","author":"Lou","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ejphar.2018.09.005_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1182\/blood.V45.3.321.321","article-title":"Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome","volume":"45","author":"Lozzio","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.09.005_bib30","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/CAD.0b013e32835ffdbb","article-title":"Histone-lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells","volume":"24","author":"Lu","year":"2013","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.ejphar.2018.09.005_bib31","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1039\/C7FO00161D","article-title":"Effects of bioactive compounds on senescence and components of senescence associated secretory phenotypes in vitro","volume":"8","author":"Maria","year":"2017","journal-title":"Food Funct."},{"key":"10.1016\/j.ejphar.2018.09.005_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-015-0721-5","article-title":"The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells","volume":"15","author":"Mayr","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.ejphar.2018.09.005_bib33","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1006\/bbrc.1998.9075","article-title":"Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins","volume":"249","author":"Naasani","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2018.09.005_bib34","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nrc3057","article-title":"Pro-senescence therapy for cancer treatment","volume":"11","author":"Nardella","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2018.09.005_bib35","first-page":"1699","article-title":"Impact of cellular senescence in aging and cancer","volume":"19","author":"Provinciali","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejphar.2018.09.005_bib36","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.leukres.2014.04.003","article-title":"Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation","volume":"38","author":"Savickiene","year":"2014","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2018.09.005_bib37","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/CAD.0000000000000122","article-title":"Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells","volume":"25","author":"Savickiene","year":"2014","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.ejphar.2018.09.005_bib38","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","article-title":"Chronic Myeloid Leukemia","volume":"340","author":"Sawyers","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2018.09.005_bib39","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2018.09.005_bib40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1593\/neo.05250","article-title":"The identification of senescence-specific genes during the induction of senescence in prostate cancer cells","volume":"7","author":"Schwarze","year":"2005","journal-title":"Neoplasia"},{"key":"10.1016\/j.ejphar.2018.09.005_bib41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.leukres.2005.05.010","article-title":"5-Aza-2\u2019-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation","volume":"30","author":"Scott","year":"2006","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejphar.2018.09.005_bib42","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/15680096113139990077","article-title":"DNA methyltransferase-1 inhibitors as epigenetic therapy for cancer","volume":"13","author":"Singh","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejphar.2018.09.005_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nrc1991","article-title":"Polycomb silencers control cell fate, development and cancer","volume":"6","author":"Sparmann","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2018.09.005_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood-2002-04-1288","article-title":"The myeloid master regulator transcription factor PU. 1 is inactivated by AML1-ETO in t ( 8; 21) myeloid leukemia","volume":"101","author":"Vangala","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2018.09.005_bib45","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.1183424","article-title":"Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML","volume":"328","author":"Zhang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2018.09.005_bib46","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00432-012-1276-1","article-title":"Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate","volume":"138","author":"Zhang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918305211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918305211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T15:15:40Z","timestamp":1571843740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918305211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":46,"alternative-id":["S0014299918305211"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.09.005","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}